Profiel
Michael Nelson is the founder of Intrommune Therapeutics, Inc. He currently holds the title of Co-President & Chief Executive Officer, which he has held since the company's founding in 2015.
Actieve functies van Michael Nelson
| Bedrijven | Functie | Begin |
|---|---|---|
Intrommune Therapeutics, Inc.
 Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Algemeen Directeur | 01-10-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Intrommune Therapeutics, Inc.
Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
